Objective: To assess the involvement of small nerve fibers in Charcot-Marie-Tooth type 1A (CMT1A).
Methods:We used indirect immunofluorescence and confocal microscopy on punch biopsies from glabrous (fingertip) and hairy (thigh and leg) skin of 20 unrelated patients with CMT1A to quantify somatic and autonomic nerve fibers. In particular, we quantified epidermal nerve fibers (ENF), Meissner corpuscles (MC), intrapapillary myelinated endings (IME), and sudomotor nerves. We correlated morphologic data with findings from quantitative sensory testing, sudomotor output, sympathetic skin response, and cardiovascular reflexes. A control population of healthy ageand sex-matched controls was included with a matching ratio of 1:2.Results: We found a length-dependent loss of ENFs that worsened with aging. We also observed a loss of MCs, IMEs, and sudomotor nerves. The loss of ENF at distal leg correlated with the increase in heat-pain thresholds (p , 0.05) and with tactile thresholds (p , 0.05). Sudomotor nerve fiber loss correlated with ENF density (p , 0.05) and sweating output (p , 0.001).
Conclusions:We demonstrated through morphologic, physical, and psychophysical testing that small somatic and autonomic fibers are abnormal and cause symptoms in patients with CMT1A. Awareness of such symptoms by the clinician could lead to better treatment. Neurology ® 2015;84:407-414 GLOSSARY ANS 5 autonomic nervous system; CGRP 5 calcitonin gene-related peptide; CMT 5 Charcot-Marie-Tooth; CMT1A 5 Charcot-Marie-Tooth type 1A; CMTNS 5 Charcot-Marie-Tooth neuropathy score; Col IV 5 collagen IV; CVR 5 cardiovascular reflexes; DST 5 dynamic sweat test; ENF 5 epidermal nerve fibers; IME 5 intrapapillary myelinated endings; LEP 5 laser-evoked potentials; MC 5 Meissner corpuscles; PGP 5 protein gene product; PMP22 5 peripheral myelin protein 22 kD; QST 5 quantitative sensory testing; SFN-SIQ 5 Small Fiber Neuropathy Symptoms Inventory Questionnaire; SSR 5 sympathetic skin response; SubP 5 substance P; VIP 5 vasoactive intestinal peptide.Charcot-Marie-Tooth (CMT) diseases are a heterogeneous group of inherited motor and sensory neuropathies with a general prevalence of 1:2,500.